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There is a need for simple asthma outcome measures for primary care which are not only valid in terms of their 
relationship with lung function but also in terms of pragmatic psychological constructs. This study assesses the 
usefulness of adding items on the degree of ‘bother’ and ‘fright’ caused by the condition to a previously validated 
simple asthma morbidity index. 
A postal questionnaire survey comprising a simple asthma morbidity index and questions on ‘fright’ and ‘bother’ 
was conducted in one general practice in the north-east of England, 
Responses were obtained from 570 individuals. Of these, 184 (32%) reported low, 133 (23%) medium and 253 
(44%) high morbidity. Twenty-nine per cent of respondents had felt frightened by their asthma in the previous 4 
weeks. Both the ‘fright’ and ‘bother’ items were significantly associated with the morbidity index. 
The addition of ‘bother’ and/or ‘fright’ questions may improve both the content, construct and predictive validity 
of the morbidity index, but this needs to be established prospectively. 
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Introduction 
Asthma remains the commonest chronic disease of any sort 
in childhood and the commonest chronic respiratory dis- 
order at any age. Both in terms of morbidity and mortality, 
the therapeutic and organizational management of this 
condition pose a considerable and continuing challenge to 
health-care delivery. One element in attempts to meet this 
challenge is the recognition of appropriate outcome 
measures to assess progress in tackling the burden of 
asthma. 
The U.K. Department of Health in 1995 commissioned a 
committee of experts, chaired by Dr Mike Pearson of 
Liverpool, to examine a wide range of possible outcome 
measures and to propose some which may be useful in 
monitoring health care across the country. Amongst the 
measures suggested in their 1996 report (1) was a short, 
pragmatic morbidity index such as that previously pro- 
posed and tested by K.J. and colleagues at Southampton 
(2,3). A number of other, undoubtedly more accurate, 
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morbidity instruments have been evaluated, such as the 
Canadian Guyatt questionnaire (4), the short-form St. 
George’s questionnaire (5) and the pair of five question sets 
proposed by Hutchinson et al. (6), but these are perhaps 
more suited to research enquiry than to routine clinical use. 
Measurement of quality of life for people with asthma 
is also considered important, but again the available 
instruments are necessarily fairly long (7). 
The original Jones morbidity index, based on the simple 
yes/no answers to three straightforward, clinically relevant 
questions and producing categories of low, medium and 
high morbidity significantly associated with lung function, 
was well received by general practitioners and found useful 
for one-off enquiries, but required the inclusion of a tem- 
poral qualifier to enable repeated testing. An improved 
relationship of the revised index to lung function has been 
established and its prospective, predictive validity has been 
demonstrated (8). Evidence of the susceptibility to change 
of the revised index in the setting of a nurse-run asthma 
clinic in primary care, and indeed of the effectiveness of 
such care, has already been reported (9). The concept of a 
short, pragmatic morbidity index for routine use seems very 
attractive but it is clearly important to investigate the 
inclusion of patient-centred constructs as well as the purely 
clinical. 
We have therefore conducted a further evaluation of the 
revised form of the Jones morbidity index using postal 
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During the last 4 weeks: 
1. Have you been in a wheezy or asthmatic condition at least once a week? 
2. Have you had time off work or school because of your asthma? 
3. Have you suffered from attacks of wheezing during the night? 
NO to all questions = LOW morbidity 
One YES answer = MEDIUM morbidity 
Two or three YES answers = HIGH morbidity 
Note: Clearly, questions 1 and 3 can be answered ‘yes’ or ‘no’ by all respondents, but question 2 will be ‘not applicable’ tc 
those who do not attend work or school. For the purposes of morbidity classification, a ‘not applicable’ answer is regarded 
similarly to ‘no’. 
FIG. 1. The revised Jones morbidity index. 
questionnaires in the setting of routine general practice to 
establish the potential benefits of adding measures of bother 
and fright to the index. 
Methods 
A two-sided postal questionnaire was sent to all those 
patients registered with one urban Tyneside practice with 
5.5 whole-time equivalent GP principals and a list size of 
just under 10 000 whose computer records indicated the 
Read code for ‘asthma NOS’. Non-responders received one 
reminder after approximately 3 weeks. The questionnaire 
comprised the three questions of the revised Jones mor- 
bidity index (which now refer to a retrospective 4-week 
period - see Fig. 1) and a short series of closed questions 
addressing four other morbidity variables covering a 
1Zmonth period, namely admission to hospital, courses of 
oral steroids required, self-report of more than four attacks 
of asthma and self-report of one or more acute attacks. The 
definition of the latter two variables was deliberately left to 
the individual respondent. 
Two further items were added to the postal question- 
naire. Firstly, subjects were asked ‘During the last 4 weeks, 
have you felt frightened because of your asthma?’ and a 
simple yes/no response was requested. Secondly, they were 
asked, ‘During the last 4 weeks, overall, how much has your 
asthma bothered you?. As this concept is likely to be more 
complex than fright and the best categories of response to 
this question had not previously been ascertained, the 
sample was allocated at random into two groups. One 
group was asked to choose one of three responses to the 
question, namely ‘no bother’, ‘moderate bother’ or ‘a lot 
of bother’, whereas the second group were offered six 
categories, ranging from ‘no bother’ to ‘makes my life a 
misery’. 
Analysis was conducted using the SPSS for Windows 
package (10). Simple frequency data with cross-tabulations, 
correlation coefficients and chi-square values are reported 
as appropriate. Relative risks and confidence intervals were 
tabled for the predictive validity data. We conducted a 
CHAID analysis (11) to determine whether further segmen- 
tation of the morbidity groups, in terms of individuals’ 
bother and fright in the previous 4 weeks, would identify 
additional statistically significant associations with adverse 
events experienced in the previous 12 months. CHAID 
(CHi-square-Automatic-Interaction-Detection) is an ex- 
ploratory decision tree algorithm that enables the handling 
of nominal categorical, ordinal categorical and continuous 
dependent variables. Decision trees are constructed by 
splitting subsets into two or more nodes repeatedly, 
beginning with the entire data set. 
Results 
The questionnaire was sent to 942 subjects, from whom 581 
replies were received (62%). The cohort of subjects recorded 
as having asthma who replied to both this and a previous 
linked survey comprised 570 individuals, though data were 
not complete on all of these. All subsequent results apply to 
this cohort with precise numbers of those with usable 
data given in each case. One hundred and eighty-four 
respondents (32%) reported low morbidity, 133 (23%) 
medium and 253 (44%) high. 
Two hundred and eighty-four respondents had received 
the three-category bother question and 286 the six-category 
version. In the former case, 87 subjects (31%) felt that they 
had experienced ‘no bother’ with their asthma, 150 (53%) 
‘moderate bother’ and 38 (13%) ‘a lot of bother’. In the 
latter case, the responses were as follows: ‘no bother’ 48 
(17%), ‘minor irritation’ 4X (17%), ‘slight bother’ 66 (23%), 
‘moderate bother’ 67 (23%): ‘a lot of bother’ 33 (12%) and 
‘makes my life a misery’ 16 (6%). 
Chi-square comparisons were made in turn for the three 
and six category versions between bother and the four 
12-month retrospective morbidity variables, namely 
admission to hospital, courses of oral steroids required, 
self-report of more than four attacks of asthma and self- 
report of one or more acute attacks. Other than with 
hospital admissions where the numbers were very low: 
statistically significant associations were found in each case 
(P<O.OOl). The distribution of bother responses and these 
associations suggested that the simpler three-category 
bother categorization was sufficient. So, for subsequent 
analyses the six-category responses have been condensed 
into three (by pairing adjacent categories together) and 
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TABLE 1. Relationship between morbidity and bother 
Morbidity 
Bother Low Medium High Totals 
Low 120 37 26 183 
Medium 45 86 152 283 
High 3 10 74 87 
252 
the whole bother data set considered together in three 
categories. 
Table 1 shows the relationship of the morbidity index 
with the bother responses. The positive correlation of 
these measures was statistically significant (Spearman’s 
rank-order correlation 0.56; P<O.OOl). 
Valid responses to the fright item were obtained from 546 
respondents. Of these, 159 (29%) indicated that they had 
felt frightened by their asthma in the previous 4 weeks. This 
percentage varied across low, medium and high morbidity 
groups, giving rates of 4% (n=8), 31% (n=88) and 73% 
(n=63), respectively. Again, this association with the 
morbidity index was statistically significant (Spear-man’s 
rank-order correlation 0.39; P<O.OOl). 
The primary interest in the bother and fright items lies in 
their potential to enhance the validity of the morbidity 
index: if one were to incorporate one or both of these 
additional items in a revised index, would one be better able 
to identify patients at high risk of adverse events? 
The results of the CHAID analysis are shown in Fig. 1. 
These tree diagrams show where a given morbidity group 
may be usefully segmented on the basis of information 
about bother or fright. Where the analysis finds that both 
extra variables are significantly associated (with reference to 
the likelihood-ratio chi-square) with the adverse event being 
considered, the one with the lowest P-value is used. In the 
case of the ‘any acute attack’ event [Fig. 2(a)], the diagram 
shows that within the low and medium morbidity groups, 
the bother and fright items give us little or no additional 
information by which to identify patients who had experi- 
enced an attack. However, within the high morbidity group, 
the analysis shows that bother can be used to separate two 
groups which have significantly different acute attack rates. 
Those with high morbidity but only low or medium bother 
show an incidence of 27%, similar to the overall rate for the 
whole sample. This contrasts with the group who suffer 
both high morbidity and high bother; 67 patients for whom 
the acute attack rate is over 62%. Among those high 
morbidity patients who do not experience high levels of 
bother, the next level of the analysis shows that the fright 
question has some discriminatory power. 
The fright item also proves useful in identifying those 
suffering more than four attacks in the previous 12 months. 
Figure 2(b) shows that both the medium and high 
morbidity groups may be usefully subdivided on the basis 
of the fright response. For the latter, bother offers a 
significant second level subdivision, giving a group of 56 
patients (23% of high morbidity cases) for which a multiple 
attack incidence of almost 90% applies. At the other end of 
the spectrum, a conjunction of low morbidity and low 
bother identifies a substantial group of patients (22% of the 
whole sample) where the relevant incidence is less than 7%. 
A more complex picture emerges when the ‘use of rescue 
steroids’ event is examined [Fig. 2(c)]. However, it is 
apparent that the bother variable is initially most useful 
in dividing up the morbidity groups. The segmentation 
yields some interesting groups; for example, those with 
high morbidity but little reported bother have an adverse 
event rate close to that seen for all those with low 
morbidity. 
Discussion 
The addition of a three category bother question and/or a 
fright question to the simple morbidity index may increase 
its usefulness in clinical practice still further. However, this 
study was conducted in the pragmatic setting of routine 
general practice and it is therefore important to consider 
what limitations this may have imposed on our data. 
The Jones morbidity index was originally proposed as a 
simple, pragmatic tool of relevance for the opportunistic 
surveillance of the activity of asthma in patients presenting 
for other purposes in primary care (2,3). Clinical experience 
with its use in different GP settings over the last 5 years 
suggests that the three-question format is valued by busy 
doctors and nurses alike and that this offers much more 
chance of widespread use than any proposal to use other 
longer, but undoubtedly more accurate asthma question- 
naires. The potential of expanding the list of questions to 
include a bother item and/or a fright item will need to be 
carefully considered and further evaluated prospectively 
before the benefits of such a change can be properly 
assessed. 
The relationship between the three-item morbidity index 
and the bother and fright items is quite complex and the 
retrospective nature of the adverse event data obtained 
means that conclusions drawn here may not be relevant to 
the predictive validity of any scale that brought the various 
items together. However, the segmentation analysis pre- 
sented here indicates that both the additional items have 
some discriminatory power with respect to adverse event 
rates within morbidity groups. It would seem that if one 
wishes to identify the groups at highest risk, best perform- 
ance is likely to come from a combination of the morbidity 
index plus both bother and fright items, although this 
needs to be confirmed against a wider range of alter- 
native outcome measures. Of the two additional items, the 
bother question appears to be somewhat better than that on 
fright. 
It is clear that all subjects with a past or present history of 
asthma experience at least some risk of potentially severe 
exacerbations of the disease. Some may therefore argue that 
all people with asthma should receive enhanced primary 
care management, but given the high prevalence of the 
condition in the community it seems important to explore 
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FIG. 2. CHAID analyses of the associations of adverse events in the previous 12 months and items relating to ‘bother’ 
and ‘fright’ in the previous 4 weeks. (a) Incidence of ‘any acute attacks’. (b) Incidence of ‘more than four attacks’. (c) Use 
of rescue oral steroids. These tree diagrams show where a given morbidity group may be usefully segmented on the basis 
of information about bother or fright. Where the analysis finds that both extra variables are significantly associated (with 
reference to the likelihood-ratio chi-square) with the adverse event being considered, the one with the lowest P-value is used. 
means of prioritizing extra care towards those most in need 
of it. Use of the Jones morbidity index must not replace 
clinical judgement but can be particularly of benefit 
where patients are consulting for other purposes, or are 
simply collecting prescriptions without seeing a health 
professional, as a simple, quick, useful and validated 
additional tool. 
The most important purpose in using any clinical 
outcome measure, such as the Jones morbidity index, is 
surely to attempt to predict those who may be at higher risk 
of adverse events in the course of their asthma. Since we 
have illustrated the potential gains in predictive accuracy 
which may result from the addition of bother and/or fright 
questions to the index, it is imperative that further research 
is conducted to assess prospectively the predictive validity 
of an enhanced index. 
A further area for future investigation may be the 
qualitative study of the small group identified as having 
high morbidity but low bother. These subjects may be 
denying their disease and may thus see little point in taking 
treatment for it. Alternatively, the responses of such sub- 
jects may indicate a measure of poor perception of asthma 
and therefore an unconscious act rather than denial. The 
best management of the so-called non-compliant patient 
may be assisted by such inquiry. 
In conclusion, therefore, the usefulness and predictive 
validity of the simple and pragmatic revised morbidity 
index may be enhanced still further by the inclusion of 
the more patient-orientated concepts of fright and 
bother. This potential needs to be established in prospective 
studies. 
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